Patent · US Active

Sigma-1 receptor ligands and methods of use

US8349898B2 · kind B2 · utility

0Cited by
2References
13Claims
0Family size

Assignee

Inventors

Key dates

Filing dateNov 18, 2009
Grant dateJan 8, 2013
Priority date
Expiry dateFeb 14, 2031

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07C211/49
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

The invention provides compounds of formula I and compositions thereof. The invention further provides methods of using the compounds and compositions. The compounds of the invention can provide high affinity binding to sigma-1 receptors in a mammal. The compounds can exhibit selectivity for the sigma-1 receptor over the sigma-2 receptor. The compounds and compositions of the invention can also be used to treat conditions that involve the sigma-1 receptor, such as addiction, cardiovascular conditions, and cancer, for example, cancer of the breast, lung, prostate, ovarian, colorectal, or the CNS.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.